PAtient Treatment Analysis: Hospital and Wide-ranging Out-of-hospital Care Assessment Yields Insights Into Heart Failure Outcomes
NCT ID: NCT06338878
Last Updated: 2024-04-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1000 participants
OBSERVATIONAL
2024-03-01
2029-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing Treatments for Heart Failure During Hospitalization
NCT05910437
Consultation at 8 Days to Reduce Hospitalisations in Heart Failure Patient
NCT01834833
Outcomes of Patients With Heart Failure Hospitalized in an Internal Medicine Unit
NCT04845126
A Study to Observe Treatment Patterns in Patients in Colombia Who Have Heart Failure
NCT05036967
French Observatory of Acute Heart Failure
NCT01080937
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients hospitalized for cardiac decompensation (ESC 2016 and 2021 criteria)
Exclusion Criteria
* Patient who is a minor or under administrative protection
* Pregnant women
* Patient with ventricular assistance
* Patient with congenital heart disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pr. Nicolas GIRERD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pr. Nicolas GIRERD
Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicolas GIRERD
Role: STUDY_CHAIR
CHRU de Nancy
Olivier HUTTIN
Role: PRINCIPAL_INVESTIGATOR
CHRU de Nancy
Laura FILIPPETTI
Role: PRINCIPAL_INVESTIGATOR
CHRU de Nancy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de Nancy
Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023PI087
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.